Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy

Hunter C. Gits, Amy H. Tang, William S. Harmsen, William R. Bamlet, Rondell P. Graham, Gloria M. Petersen, Thomas C. Smyrk, Amit Mahipal, Roman O. Kowalchuk, Jonathan B. Ashman, William G. Rule, Dawn Owen, Michelle A. Neben Wittich, Robert R. McWilliams, Thorvardur Halfdanarson, Wen Wee Ma, Terence T. Sio, Sean P. Cleary, Mark J. Truty, Michael G. HaddockChristopher L. Hallemeier, Kenneth W. Merrell

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Intact SMAD-4 is a predictor of increased locoregional recurrence in upfront resected pancreas cancer receiving adjuvant therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences